CHA2DS2-VASc Calculator
Use this tool to estimate stroke risk in patients with non-valvular atrial fibrillation.
Educational use only. This calculator supports clinical discussion and does not replace individualized medical judgment.
What is the CHA2DS2-VASc score?
The CHA2DS2-VASc score is a widely used clinical risk stratification tool for estimating annual stroke risk in patients with non-valvular atrial fibrillation (AF). It improves on the older CHADS2 model by including additional risk factors, especially vascular disease, age 65–74, and sex category.
In practical terms, this score helps clinicians decide whether the expected benefit of anticoagulation outweighs potential bleeding risk. It is one of the most common first steps in AF stroke-prevention planning.
How scoring works
Point assignment
- Congestive heart failure / LV dysfunction: 1 point
- Hypertension: 1 point
- Age ≥ 75 years: 2 points
- Diabetes mellitus: 1 point
- Stroke/TIA/thromboembolism history: 2 points
- Vascular disease: 1 point
- Age 65–74 years: 1 point
- Sc (sex category female): 1 point
Maximum total score is 9 points. Age contributes either 0, 1, or 2 points (not both age categories together).
Approximate annual stroke risk by score
Published risk percentages differ across cohorts and guideline updates. The following values are commonly cited approximations:
| CHA2DS2-VASc Score | Estimated Annual Stroke Risk |
|---|---|
| 0 | ~0.0% |
| 1 | ~1.3% |
| 2 | ~2.2% |
| 3 | ~3.2% |
| 4 | ~4.0% |
| 5 | ~6.7% |
| 6 | ~9.8% |
| 7 | ~9.6% |
| 8 | ~6.7% |
| 9 | ~15.2% |
How to interpret results
General framework used in many practices
- Lower risk: Often no anticoagulation (depending on sex category and full context).
- Intermediate risk: Consider anticoagulation after shared decision-making.
- Higher risk: Anticoagulation is often recommended if no major contraindications.
Guideline thresholds differ slightly between societies and evolve over time. Bleeding risk, patient preferences, frailty, renal function, drug interactions, and fall risk should all be part of the final decision.
CHA2DS2-VASc vs CHADS2
The older CHADS2 score is simpler, but it can classify some moderate-risk patients as low risk. The CHA2DS2-VASc score adds granularity by recognizing additional risk factors and age bands, which improves discrimination in clinical practice.
For this reason, most modern AF guidelines favor CHA2DS2-VASc for routine risk assessment.
Important limitations
- It estimates population-level risk; individual risk can differ.
- It does not directly measure bleeding risk (tools like HAS-BLED are often used separately).
- Not a substitute for physician assessment in valvular AF, severe kidney disease, pregnancy, or complex comorbidity.
- A single score should not overrule patient-centered clinical judgment.
Frequently asked questions
Does female sex alone mean anticoagulation is required?
Usually no. Female sex category can be a risk modifier, and many recommendations consider anticoagulation when there are additional non-sex risk factors.
Can this calculator diagnose atrial fibrillation?
No. It only estimates stroke risk after AF has already been diagnosed.
Should I stop or start blood thinners based only on this page?
No. Medication decisions must be made with a licensed clinician who can assess your full medical history, bleeding risk, and treatment goals.
Bottom line
The CHA2DS2-VASc score is a practical, evidence-based way to estimate stroke risk in non-valvular AF and guide discussion about anticoagulation. Use it as a starting point, not the final word.